Enoxaparin PCD Pharma Franchise Company
Cafoli Lifecare offers an Enoxaparin PCD pharma franchise built on 2 injectable formulations manufactured at WHO-GMP certified facilities. This gives franchise partners a critical-care anticoagulant line for hospital, cardiology and surgical channels.
What is Enoxaparin?
Enoxaparin is a low-molecular-weight heparin (LMWH) that acts as an anticoagulant mainly by potentiating antithrombin-mediated inhibition of factor Xa. It offers predictable dosing and does not usually require routine coagulation monitoring, making it a mainstay for the prevention and treatment of venous thromboembolism. Read its profile on MedlinePlus.
Therapeutic Applications
Enoxaparin is used for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism, in acute coronary syndromes (unstable angina and myocardial infarction), and for thromboprophylaxis in surgical and immobilised patients. It is administered as a pre-filled subcutaneous injection. Prescribers include cardiologists, surgeons, orthopaedic surgeons, intensivists and physicians.
Why Enoxaparin is a High-Potential Molecule for Distributors
Enoxaparin is a standing-order product in almost every hospital — thromboprophylaxis is routine after surgery, in cardiac care and during prolonged admissions — so institutional demand is steady and largely tender-driven. Its pre-filled syringe format commands a good value per unit and rising rates of cardiac and orthopaedic procedures keep the category growing. For a distributor with hospital accounts, it is a dependable high-value line.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.
References
- MedlinePlus: Enoxaparin
- WHO Model List of Essential Medicines
Our formulations of Enoxaparin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: